198 related articles for article (PubMed ID: 12527776)
1. Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA.
Czauderna F; Fechtner M; Aygün H; Arnold W; Klippel A; Giese K; Kaufmann J
Nucleic Acids Res; 2003 Jan; 31(2):670-82. PubMed ID: 12527776
[TBL] [Abstract][Full Text] [Related]
2. Inducible shRNA expression for application in a prostate cancer mouse model.
Czauderna F; Santel A; Hinz M; Fechtner M; Durieux B; Fisch G; Leenders F; Arnold W; Giese K; Klippel A; Kaufmann J
Nucleic Acids Res; 2003 Nov; 31(21):e127. PubMed ID: 14576327
[TBL] [Abstract][Full Text] [Related]
3. GeneBlocs are powerful tools to study and delineate signal transduction processes that regulate cell growth and transformation.
Sternberger M; Schmiedeknecht A; Kretschmer A; Gebhardt F; Leenders F; Czauderna F; Von Carlowitz I; Engle M; Giese K; Beigelman L; Klippel A
Antisense Nucleic Acid Drug Dev; 2002 Jun; 12(3):131-43. PubMed ID: 12162696
[TBL] [Abstract][Full Text] [Related]
4. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells.
Czauderna F; Fechtner M; Dames S; Aygün H; Klippel A; Pronk GJ; Giese K; Kaufmann J
Nucleic Acids Res; 2003 Jun; 31(11):2705-16. PubMed ID: 12771196
[TBL] [Abstract][Full Text] [Related]
5. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells.
Kawasaki H; Taira K
Nucleic Acids Res; 2003 Jan; 31(2):700-7. PubMed ID: 12527779
[TBL] [Abstract][Full Text] [Related]
6. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
Zhang D; Brodt P
Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
[TBL] [Abstract][Full Text] [Related]
7. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis.
Vickers TA; Koo S; Bennett CF; Crooke ST; Dean NM; Baker BF
J Biol Chem; 2003 Feb; 278(9):7108-18. PubMed ID: 12500975
[TBL] [Abstract][Full Text] [Related]
8. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.
Li DM; Sun H
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981
[TBL] [Abstract][Full Text] [Related]
9. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
10. Transient strong reduction of PTEN expression by specific RNAi induces loss of adhesion of the cells.
Mise-Omata S; Obata Y; Iwase S; Mise N; Doi TS
Biochem Biophys Res Commun; 2005 Mar; 328(4):1034-42. PubMed ID: 15707982
[TBL] [Abstract][Full Text] [Related]
11. Constitutive cellular expression of PI 3-kinase is distinct from transient expression.
Auger KR; Wang J; Narsimhan RP; Holcombe T; Roberts TM
Biochem Biophys Res Commun; 2000 Jun; 272(3):822-9. PubMed ID: 10860837
[TBL] [Abstract][Full Text] [Related]
12. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel effectors of invasive cell growth downstream of phosphoinositide 3-kinase.
Kaufmann J; Pronk G; Giese K; Klippel A
Biochem Soc Trans; 2004 Apr; 32(Pt 2):355-9. PubMed ID: 15046608
[TBL] [Abstract][Full Text] [Related]
14. Expressing functional siRNAs in mammalian cells using convergent transcription.
Tran N; Cairns MJ; Dawes IW; Arndt GM
BMC Biotechnol; 2003 Nov; 3():21. PubMed ID: 14604435
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
[TBL] [Abstract][Full Text] [Related]
16. A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens.
Hsieh AC; Bo R; Manola J; Vazquez F; Bare O; Khvorova A; Scaringe S; Sellers WR
Nucleic Acids Res; 2004; 32(3):893-901. PubMed ID: 14769947
[TBL] [Abstract][Full Text] [Related]
17. [Genetic abnormalities in endometrial cancer].
Takeshima N; Hirai Y
Nihon Rinsho; 2004 Oct; 62 Suppl 10():254-8. PubMed ID: 15535246
[No Abstract] [Full Text] [Related]
18. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
19. Targeted RNA interference of phosphatidylinositol 3-kinase p110-beta induces apoptosis and proliferation arrest in endometrial carcinoma cells.
An HJ; Cho NH; Yang HS; Kwak KB; Kim NK; Oh DY; Lee SW; Kim HO; Koh JJ
J Pathol; 2007 Jun; 212(2):161-9. PubMed ID: 17427168
[TBL] [Abstract][Full Text] [Related]
20. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex.
Zhang C; Comai L; Johnson DL
Mol Cell Biol; 2005 Aug; 25(16):6899-911. PubMed ID: 16055704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
